Rituximab, a viable alternative for induction therapy of active lupus nephritis.
作者信息
Zhou Xu-jie, Zhao Ming-hui, Zhang Hong
机构信息
Renal Division, Peking University First Hospital, Peking University Institute of Nephrology, Key Laboratory of Renal Disease, Ministry of Health of China and Key Laboratory of Chronic Kidney Disease Prevention and Treatment (Peking University), Ministry of Education, Beijing, People's Republic of China.Renal Division, Peking University First Hospital, Peking University Institute of Nephrology, Key Laboratory of Renal Disease, Ministry of Health of China and Key Laboratory of Chronic Kidney Disease Prevention and Treatment (Peking University), Ministry of Education, Beijing, People's Republic of China.Renal Division, Peking University First Hospital, Peking University Institute of Nephrology, Key Laboratory of Renal Disease, Ministry of Health of China and Key Laboratory of Chronic Kidney Disease Prevention and Treatment (Peking University), Ministry of Education, Beijing, People's Republic of China.
出版信息
Rheumatology (Oxford). 2014 Sep;53(9):1537-8. doi: 10.1093/rheumatology/keu152. Epub 2014 Apr 12.
Zotero 插件